Evaluation of Performance and Safety of Colonic Irrigation With the Colon Hydromat as a Non-oral Bowel Preparation for Colonoscopy

February 3, 2021 updated by: Herrmann Apparatebau GmbH

Prospective, Single-center, Single-arm, Open-label Observational PMCF Study - Evaluation of Performance and Safety of Colonic Irrigation With the Colon Hydromat as a Non-oral Bowel Preparation for Colonoscopy

This is a clinical study with a medical device that bears the CE mark (approval for marketing in the EU) and is applied within its intended use. It is a prospective, single-centre, single-arm, open-label, observational post-market clinical follow-up (PMCF) study using the "Colon Hydromat" system for bowel preparation prior to colonoscopy. The patients will be treated according to the clinical routine and in accordance with the current IFU.

Aim of the study is to confirm safety and performance (effectiveness) of colon hydrotherapy as bowel preparation for colonoscopy. Colonic irrigation is regarded as a substitute for standard oral colonic purgative solutions for colonoscopy preparation, especially for patients, who cannot tolerate oral preparations or want to have alternatives because they have experienced the current oral preparations as a burdensome process.

Study Overview

Status

Unknown

Conditions

Detailed Description

This observational study is intended to answer the question, if the colon hydrotherapy (colonic irrigation with the "Colon Hydromat") works in real-life practice.

Colonic irrigation is regarded as a substitute for standard oral colonic purgative solutions for colonoscopy preparation. The advantage of colonic irrigation is that there is no unpleasant taste, it avoids the discomfort of diarrheic episode and there is no need to drink a large volume of water or fluids. The patient will receive the bowel irrigation with the "Colon Hydromat" directly before colonoscopy, at the same day. Aim of this study is to confirm performance (effectiveness), in terms of an adequate bowel preparation and safety of the "Colon-Hydromat", as alternative bowel cleansing device prior to colonoscopy. The primary performance (effectiveness) endpoint for this study is the colonic cleanliness, defined as overall quality of bowel cleansing as measured by the Boston Bowel Preparation Scale (BBPS). The primary safety endpoints for this study are adverse device events (ADE) and serious adverse device effects (SADE), product and procedure related.

Study Type

Observational

Enrollment (Anticipated)

28

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Leipzig, Germany, 04105
        • Recruiting
        • Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselerkrankungen
        • Contact:
          • Niels Teich, Prof.
          • Phone Number: +49 34204 7200
          • Email: teich@igvs.de

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients (men and women) who are planned for a colonoscopy and where anorectal colonic irrigation with the specula can be performed, will be included into the study.

The colonic irrigation is regarded as alternative bowel preparation to oral preparations, especially for patients who:

  • cannot tolerate oral preparations (e.g. cannot drink large volumes, nausea, vomiting), or
  • want to have alternatives because they have experienced the current oral preparations as a burdensome process, or
  • had an inadequate colon cleansing following traditional oral preparation, in order to complete the colonoscopy at the same day.

Description

Inclusion Criteria:

  • Patients with an indication of colonoscopy: inclusion is considered if patients require a colonoscopy and
  • desire an alternative bowel preparation method to standard of oral polyethylene glycol or other orally taken purgatives, or do not tolerate the oral preparations, or had an inadequate colon cleansing following traditional oral preparation, in order to complete the colonoscopy at the same day.
  • Adult patients (≥ 18 years old) having signed the informed consent.
  • Being able to respond to the self-administered questionnaire.

Exclusion Criteria:

  • Psychiatric conditions and inability to provide informed consent
  • Emergency colonoscopy
  • Off-label use (application is not within the IFU)
  • Pregnancy and lactation period
  • The patient has one of the contraindications listed in the IFU.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Single Group Assignment
Patients will receive colonic irrigation as bowel preparation prior to colonoscopy.
A designated health professional will administer to the patient the colonic irrigation procedure - using the "Colon Hydromat" device, a CE certified device for colonic irrigation and cleansing before endoscopic procedures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of bowel preparation (Colonic Cleanliness), evaluated through the Boston Bowel Preparation Scale (BBPS).
Time Frame: day 1
Quality of bowel preparation validated by numerical scale for bowel cleanse (0-9 best)
day 1
Adverse device events (ADE) and collection of SADE (device or procedure related).
Time Frame: day 1
Assessment of ADE: Patients will be asked in questionnaires, if they had any adverse events, especially nausea, vomiting, pain/cramps, dizziness and headache and rate of patients where colonic irrigation had to be aborted. Assessment of SADE: will be assessed at end of colonoscopy by investigator.
day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BBPS for each segment.
Time Frame: day 1
BBPS will be assessed in each bowel segment (left, transverse, right).
day 1
Patient satisfaction.
Time Frame: day 1
Patient satisfaction with respect to convenience and comfort/ discomfort, and preference/acceptance, as evaluated by a questionnaire (questions to the patient; no score).
day 1
User satisfaction and usability.
Time Frame: day 1
User satisfaction and usability, as measured by a questionnaire (questions to the patient; no score).
day 1
Details to colonic irrigation.
Time Frame: day 1
Time taken to complete the colon irrigation with the "Colon Hydromat".
day 1
Details to colonic irrigation.
Time Frame: day 1
Number of cycles used for cleaning the colon.
day 1
Details to colonic irrigation.
Time Frame: day 1
Volume of water used for cleaning the colon.
day 1
Colonoscopic findings.
Time Frame: day 1

Characteristics of all polyps/lesions detected:

Location (right, transverse, or left colon) and size.

General assessment of colon anatomy and other circumstances related to the colon:

No abnormality detected / tortuous / very long/ diverticular disease / stenosis / severe constipation / weak muscle tone of the sphincter - build-up of pressure was insufficient.

day 1
Rate of colonoscopy termination.
Time Frame: day 1
Rate of colonoscopy termination due to inadequate bowel preparation.
day 1
Procedure time of colonoscopy.
Time Frame: day 1
Procedure time of colonoscopy (time from intubation to withdrawal).
day 1
Withdrawal time.
Time Frame: day 1
Withdrawal time: the total time for withdrawal from cecum to anus; this includes all interventions or delays (e.g. biopsies, polypectomies…).
day 1
Cecal intubation rate.
Time Frame: day 1
Cecal intubation rate (reaching the cecum or anastomosis, if present).
day 1
Runway time.
Time Frame: day 1
Time interval between the patient's end of bowel cleaning / colonic irrigation and the moment of colonoscope insertion.
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Niels Teich, Prof. Dr. med., Study centre Leipzig - Internistic Joint Practice

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 3, 2021

Primary Completion (Anticipated)

March 15, 2021

Study Completion (Anticipated)

March 30, 2021

Study Registration Dates

First Submitted

December 16, 2020

First Submitted That Met QC Criteria

December 21, 2020

First Posted (Actual)

December 24, 2020

Study Record Updates

Last Update Posted (Actual)

February 8, 2021

Last Update Submitted That Met QC Criteria

February 3, 2021

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • HRR015CHT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Irrigation

Clinical Trials on Colonic irrigation with the Colon Hydromat

3
Subscribe